Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 27, Issue 9, 2012, Pages 3482-3488

  Rizk, Dana V ^a   Gutierrez, Orlando ^a   Levitan, Emily B ^b   McClellan, William M ^b,c   Safford, Monika ^d   Soliman, Elsayed Z ^e   Warnock, David G ^a   Muntner, Paul ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University of Alabama at Birmingham   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

chronic kidney disease; coronary artery disease; mortality

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; SELF REPORT; UNRECOGNIZED MYOCARDIAL INFARCTION;

ADULT; AGED; ALBUMINURIA; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; MYOCARDIAL INFARCTION; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVIVAL RATE;

EID: 84865729546     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr684     Document Type: Article

References (24)

1. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA 1983; 250: 1757-1765.
2. Sheifer SE, Gersh BJ, Yanez D et al. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. J Am Coll Cardiol 2000; 35: 119-126.
3. Sigurdsson E, Thorgeirsson G, Sigvaldason H et al. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med 1995; 122: 96-102.
4. Jonsdottir LS, Sigfusson N, Sigvaldason H et al. Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. Eur Heart J 1998; 19: 1011-1018.
5. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med 1984; 1: 1144-1147.
6. Grimm RH, Tillinghast S, Daniels K et al. Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT). Circulation 1987; 75 (Suppl II): II6-II8.
7. Margolis JR, Kannel WB, Feinleib M et al. Clinical features of unrecognized myocardial infarction-silent and symptomatic: eighteen year follow-up: the Framingham study. Am J Cardiol 1973; 32: 1-7.
8. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
9. Astor BC, Hallan SI, Miller ER, 3rd et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008; 167: 1226-1234.
10. McCullough PA, Li S, Jurkovitz CT et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008; 51: S38-S45.
11. Beattie JN, Soman SS, Sandberg KR et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001; 37: 1191-1200.
12. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805.
13. Howard VJ, Cushman M, Pulley L et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology 2005; 25: 135-143.
14. Callahan CM, Unverzagt FW, Hui SL et al. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care 2002; 40: 771-781.
15. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
16. Bolton K, Coresh J, Culleton B et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2007; 39: S1-S266.
17. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Bristol, UK: John Wright PSG; 1982.
18. Medalie JH, Goldbourt U. Unrecognized myocardial infarction: fiveyear incidence, mortality, and risk factors. Ann Intern Med 1976; 84: 526-531.
19. Walker MK, Whincup PH, Shaper AG et al. Validation of patient recall of doctor-diagnosed heart attack and stroke: a postal questionnaire and record review comparison. Am J Epidemiol 1998; 148: 355-361.
20. Okura Y, Urban LH, Mahoney DW et al. Agreement between selfreport questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004; 57: 1096-1103.
21. Yamagishi K, Ikeda A, Iso H et al. Self-reported stroke and myocardial infarction had adequate sensitivity in a population-based prospective study JPHC (Japan Public Health Center)-based Prospective Study. J Clin Epidemiol 2009; 62: 667-673.
22. Lindberg HA, Berkson DM, Stamler J et al. Totally asymptomatic myocardial infarction: an estimate of its incidence in the living population. Arch Intern Med 1960; 106: 628-633.
23. McClellan W, Warnock DG, McClure L et al. Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol 2006; 17: 1710-1715.
24. Kottke TE, Daida H, Bailey KR et al. Reliability of the Minnesota and Mayo electrocardiographic coding systems. J Electrocardiol 1998; 4: 303-312.